Holland & Knight’s Michael Werner talks to Dr. Russell Medford, President and CEO of Salutria Pharmaceuticals, a privately-held biotech company based in Alpharetta Georgia. Dr. Medford is also co-chair of BIO’s Board Standing Committee on Bioethics. Dr. Medford will be providing testimony on Wednesday November 16 to the Presidential Commission for the Study of Bioethical Issues on Principles Regarding Ethical Performance of International Clinical Trials.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
TagsFood public policy Sustainability patent climate change BIO International Convention global food crisis biofuels healthcare agriculture Health Care Intellectual Property biotech industry Benefits of biotech crops Plant biotechnology health BIO BIO EVENT FDA biotechnology
- Most Popular
Latest VideoJohn Chambers, Vice Chairman, Head of Healthcare Investment Banking, ROTH Capital Partners View All >